We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 86

U.S. Supreme Court refines & limits antitrust state action defense
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • February 26 2015

On February 25, 2015, the United States Supreme Court issued a 6-3 opinion in North Carolina State Bd of Dental Examiners v. FTC, which held that a


Anti-assignment provisions and providers
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • August 6 2015

Beginning last year, there has been a rash of court decisions giving ERISA participant andor beneficiary status to providers based on assignments


FTC v. St. Luke's Health System, Ltd.: Ninth Circuit holds that acquisition of physician group practice violates antitrust laws, requires divestiture
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • February 11 2015

On February 10, 2015, the Ninth Circuit affirmed a district court ruling in favor of the Federal Trade Commission that the acquisition of an Idaho


Federal circuit applies ariad analysis to dna and protein claims in interference
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • September 21 2010

The written description requirement of 35 U.S.C. 112 can play a critical role in interferences as well as patent prosecution and litigation


Disability claims procedures get an Affordable Care Act makeover
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • November 18 2015

In light of the volume of litigation involving claims for disability benefits, and the perceived need to improve procedural protections for workers


Dueling court cases issued on same day
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • July 24 2014

On Tuesday morning the U.S. Court of Appeals for the District of Columbia Circuit ruled that an IRS rule for a key piece of the 2010 Affordable Care


Amgen v Apotex - 180-Day Advance Notice of Biosimilar Marketing is Mandatory
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • December 11 2015

The Federal Circuit in July said in its Amgen-Sandoz decision that declining to share information under the biosimilars pathway "patent dance" made


FTC v. Actavis
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • June 21 2013

On June 17, 2013, the Supreme Court issued an opinion authored by Justice Breyer in FTC v. Actavis, holding that "reverse payment" settlements are


FTC v. Phoebe Putney Health System, Inc., et al.
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • February 20 2013

On February 19, 2013, the United States Supreme Court in Federal Trade Commission v. Phoebe Putney Health System, Inc., et al., unanimously rejected


Participants sue wellness program
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • February 14 2011

Last week a federal district court in Florida certified a class action against Broward County Florida's health plan